Prions, transmissible agents that cause Creutzfeldt–Jakob disease (CJD) and other prion diseases, are known to resist conventional sterilization procedures. Iatrogenic transmission of classical CJD via neurosurgical instruments is well documented and the involvement of lymphoreticular tissues in variant CJD (vCJD), together with the unknown population prevalence of asymptomatic vCJD infection, has led to concerns about transmission from a wide range of surgical procedures. To address this problem, conditions were sought that destroy PrPSc from vCJD-infected human tissue and eradicate RML prion infectivity adsorbed onto surgical steel. Seven proteolytic enzymes were evaluated individually and in pairs at a range of temperatures and pH values and the additional effects of detergents, lipases and metal ions were assessed. A combination of proteinase K and Pronase, in conjunction with SDS, was shown to degrade PrPSc material from highly concentrated vCJD-infected brain preparations to a level below detection. When RML prion-infected wires were exposed to the same enzymic treatment, intracerebral bioassay in highly susceptible hosts showed virtually no infectivity. The prion-degrading reagents identified in this study are readily available, inexpensive, non-corrosive to instruments, non-hazardous to staff and compatible with current equipment and procedures used in hospital sterilization units.
AsanteE. A.,
LinehanJ. M.,
DesbruslaisM.8 other authors2002; BSE prions propagate as either variant CJD-like or sporadic CJD-like prion strains in transgenic mice expressing human prion protein. EMBO J 21:6358–6366[CrossRef]
BrownP.,
GibbsC. J.Jr,
Rodgers JohnsonP.,
AsherD. M.,
SulimaM. P.,
BacoteA.,
GoldfarbL. G.,
GajdusekD. C.1994; Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol 35:513–529[CrossRef]
BruceM. E.,
WillR. G.,
IronsideJ. W.10 other authors1997; Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agent. Nature 389:498–501[CrossRef]
CarlsonG. A.,
KingsburyD. T.,
GoodmanP. A.,
ColemanS.,
MarshallS. T.,
DeArmondS. J.,
WestawayD.,
PrusinerS. B.1986; Linkage of prion protein and scrapie incubation time genes. Cell 46:503–511[CrossRef]
CollingeJ.,
SidleK. C. L.,
MeadsJ.,
IronsideJ.,
HillA. F.1996; Molecular analysis of prion strain variation and the aetiology of ‘new variant’ CJD. Nature 383:685–690[CrossRef]
CooperJ. D.,
BirdS. M.2002a; UK bovine carcass meat consumed as burgers, sausages and other meat products: by birth cohort and gender. J Cancer Epidemiol Prev 7:49–57[CrossRef]
CooperJ. D.,
BirdS. M.2002b; UK dietary exposure to BSE in beef mechanically recovered meat: by birth cohort and gender. J Cancer Epidemiol Prev 7:59–70[CrossRef]
GhaniA. C.,
DonnellyC. A.,
FergusonN. M.,
AndersonR. M.2003; Updated projections of future vCJD deaths in the UK. BMC Infect Dis 3:4 [View Article]10.1186/1471-2334-3-4
GlatzelM.,
AbelaE.,
MaissenM.,
AguzziA.2003; Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease. N Engl J Med 349:1812–1820[CrossRef]
HillA. F.,
ButterworthR. J.,
JoinerS.12 other authors1999; Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet 353:183–189[CrossRef]
HiltonD. A.,
SutakJ.,
SmithM. E.8 other authors2004; Specificity of lymphoreticular accumulation of prion protein for variant Creutzfeldt-Jakob disease. J Clin Pathol 57:300–302[CrossRef]
JoinerS.,
LinehanJ.,
BrandnerS.,
WadsworthJ. D.,
CollingeJ.2002; Irregular presence of abnormal prion protein in appendix in variant Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 73:597–598[CrossRef]
LangeveldJ. P.,
WangJ. J.,
Van de WielD. F.,
ShihG. C.,
GarssenG. J.,
BossersA.,
ShihJ. C.2003; Enzymatic degradation of prion protein in brain stem from infected cattle and sheep. J Infect Dis 188:1782–1789[CrossRef]
LlewelynC. A.,
HewittP. E.,
KnightR. S.,
AmarK.,
CousensS.,
MackenzieJ.,
WillR. G.2004; Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 363:417–421[CrossRef]
LloydS. E.,
OnwuazorO. N.,
BeckJ. A.,
MallinsonG.,
FarrallM.,
TargonskiP.,
CollingeJ.,
FisherE. M. C.2001; Identification of multiple quantitative trait loci linked to prion disease incubation period in mice. Proc Natl Acad Sci U S A 98:6279–6283[CrossRef]
McLeodA. H.,
MurdochH.,
DickinsonJ.7 other authors2004; Proteolytic inactivation of the bovine spongiform encephalopathy agent. Biochem Biophys Res Commun 317:1165–1170[CrossRef]
PanK.-M.,
BaldwinM. A.,
NguyenJ.8 other authors1993; Conversion of α -helices into β -sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci U S A 90:10962–10966[CrossRef]
SomervilleR. A.,
OberthurR. C.,
HavekostU.,
MacDonaldF.,
TaylorD. M.,
DickinsonA. G.2002; Characterization of thermodynamic diversity between transmissible spongiform encephalopathy agent strains and its theoretical implications. J Biol Chem 277:11084–11089[CrossRef]
TaylorD. M.,
FraserH.,
McConnellI.,
BrownD. A.,
BrownK. L.,
LamzaK. A.,
SmithG. R. A.1994; Decontamination studies with the agents of bovine spongiform encephalopathy and scrapie. Arch Virol 139:313–326[CrossRef]
TaylorD. M.,
FernieK.,
SteeleP. J.,
McConnellI.,
SomervilleR. A.2002; Thermostability of mouse-passaged BSE and scrapie is independent of host PrP genotype: implications for the nature of the causal agents. J Gen Virol 83:3199–3204
WadsworthJ. D. F.,
JoinerS.,
HillA. F.,
CampbellT. A.,
DesbruslaisM.,
LuthertP. J.,
CollingeJ.2001; Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Lancet 358:171–180[CrossRef]
YanZ. X.,
StitzL.,
HeegP.,
PfaffE.,
RothK.2004; Infectivity of prion protein bound to stainless steel wires: a model for testing decontamination procedures for transmissible spongiform encephalopathies. Infect Control Hosp Epidemiol 25:280–283[CrossRef]